Advertisement

HPV vaccination through age 45 in the US: small benefit, high cost

    • 4 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Subscribe to journal

    Immediate online access to all issues from 2019. Subscription will auto renew annually.

    US$ 214

    This is the net price. Taxes to be calculated in checkout.

    Reference

    1. Laprise JF, et al. Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States. Annals of Internal Medicine : 10 Dec 2019. Available from: URL: http://doi.org/10.7326/M19-1182

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    HPV vaccination through age 45 in the US: small benefit, high cost. PharmacoEcon Outcomes News 844, 19 (2020). https://doi.org/10.1007/s40274-020-6482-5

    Download citation